Charles J. Dockendorff - 07 Mar 2024 Form 4 Insider Report for HOLOGIC INC (HOLX)

Role
Director
Signature
/s/ Mark W. Irving, attorney-in-fact for Mr. Dockendorff
Issuer symbol
HOLX
Transactions as of
07 Mar 2024
Net transactions value
-$111,648
Form type
4
Filing time
11 Mar 2024, 18:45:17 UTC
Previous filing
04 Jan 2024
Next filing
26 Mar 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOLX Common Stock Award +1,572 +107% 3,037 07 Mar 2024 Direct F1, F2
transaction HOLX Common Stock Sale $111,648 -1,465 -48% $76.21 1,572 08 Mar 2024 Direct F3
holding HOLX Common Stock 15,370 07 Mar 2024 Revocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOLX Non-qualified Stock Option (Right to Buy) Award $0 +4,536 $0.000000 4,536 07 Mar 2024 Common Stock 4,536 $76.32 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents restricted stock units which vest on the date of the 2025 Annual Meeting of Stockholders and are settled in shares of common stock.
F2 Restricted stock units are settled in shares of common stock on a one-for-one basis.
F3 Transaction pursuant to an existing Rule 10b5-1 trading plan adopted May 24, 2023.
F4 Options become exercisable on the date of the 2025 Annual Meeting of Stockholders.